XML 45 R34.htm IDEA: XBRL DOCUMENT v3.19.2
Accrued Liabilities (Tables)
6 Months Ended
Jun. 28, 2019
Accrued Liabilities [Abstract]  
Schedule of Accrued Liabilities [Table Text Block]

Accrued liabilities in the Condensed Consolidated Balance Sheets consisted of the following:

 
June 28, 2019
 
December 31, 2018
 
(In thousands)
Accrued payroll
$
92,258

 
$
72,216

Accrued taxes
56,712

 
55,554

Accrued asbestos-related liability
60,015

 
56,045

Warranty liability - current portion
14,281

 
12,312

Accrued restructuring liability - current portion
9,739

 
5,475

Accrued third-party commissions
26,881

 
15,765

Lease liability - current portion
34,524

 

Accrued interest
28,497

 
2,956

Other
125,651

 
53,694

Accrued liabilities
$
448,558

 
$
274,017



Schedule of Product Warranty Liability [Table Text Block]
The activity in the Company’s warranty liability consisted of the following:
 
Six Months Ended
 
June 28, 2019
 
June 29, 2018
 
(In thousands)
Warranty liability, beginning of period
$
12,312

 
$
10,949

Accrued warranty expense
4,163

 
4,318

Changes in estimates related to pre-existing warranties
764

 
293

Cost of warranty service work performed
(5,101
)
 
(3,786
)
Acquisition-related liability
2,113

 

Foreign exchange translation effect
30

 
(331
)
Warranty liability, end of period
$
14,281

 
$
11,443



Schedule of Restructuring Reserve by Type of Cost [Table Text Block] A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Condensed Consolidated Balance Sheets is as follows:
 
Six Months Ended June 28, 2019
 
Balance at Beginning of Period
 
Acquisitions
 
Provisions
 
Payments
 
Foreign Currency Translation
 
Balance at End of Period(3)
 
(In thousands)
Restructuring and other related charges:
 
 
 
 
 
 
 
 
 
 
 
Fabrication Technology:
 
 
 
 
 
 
 
 
 
 
 
Termination benefits(1)
$
5,494

 
$

 
$
3,804

 
$
(6,746
)
 
$
(300
)
 
$
2,252

Facility closure costs(2)
662

 

 
4,432

 
(5,118
)
 
30

 
6

 
6,156

 

 
8,236

 
(11,864
)
 
(270
)
 
2,258

Non-cash charges(2)
 
 

 
139

 
 
 
 
 
 
 
 
 


 
8,375

 
 
 
 
 
 
Medical Technology:
 
 
 
 
 
 
 
 
 
 
 
Termination benefits(1)

 
5,922

 
3,618

 
(3,656
)
 
(28
)
 
5,856

Facility closure costs(2)

 

 
25,422

 
(19,779
)
 

 
5,643

 

 
5,922

 
29,040

 
(23,435
)
 
(28
)
 
11,499

Total
$
6,156

 
$
5,922

 
$
37,276

 
$
(35,299
)
 
$
(298
)
 
$
13,757

Non-cash charges(2)
 
 
 
 
139

 
 
 
 
 
 
 
 
 
 
 
$
37,415

 
 
 
 
 
 
 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment and lease termination expense in connection with the closure of facilities. During the six months ended June 28, 2019, the Company recorded an $0.1 million non-cash impairment charge for facilities in our Fabrication Technology segment as part of Corporate approved restructuring activities. Restructuring charges in our Medical Technology segment during the six months ended June 28, 2019 includes costs related to product and distribution channel transformations, facilities optimization, and integration charges.
(3) As of June 28, 2019, $9.7 million and $4.0 million of the Company’s restructuring liability was included in Accrued liabilities and Other liabilities, respectively.